Dr. Lal PathLabs Ltd - 539524 - Compliance Under Regulation 23(9) Of SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015
With reference to the captioned subject, please find the enclosed herewith Related Party Transactions of the Company for the half year ended September 30, 2022. Dr. Lal PathLabs Ltd - 539524 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
Pursuant to Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, Please find attached the details of the proposed schedule of Analyst/Institutional Investor meeting(s). Dr. Lal PathLabs Ltd - 539524 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
Pursuant to Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, Please find attached the details of the proposed schedule of Analyst/Institutional Investor meeting(s). Dr. Lal PathLabs Ltd - 539524 - Announcement under Regulation 30 (LODR)-Newspaper Publication
Please find enclosed herewith e-copy of newspaper advertisements published today i.e. November 15, 2022 in Financial Express (English Edition) and Jansatta (Hindi Edition), with respect to completion of dispatch of Postal Ballot Notice dated November 08, 2022, electronically, to the Shareholders of the Company. We request you to kindly take the same on record. Dr. Lal PathLabs Ltd - 539524 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
Pursuant to Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, Please find attached the details of the proposed schedule of Analyst/Institutional Investor meeting(s). Dr. Lal PathLabs Ltd - 539524 - Announcement under Regulation 30 (LODR)-Earnings Call Transcript
Pursuant to Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, please find attached herewith Financial Results Conference Call Transcript of the Company for Q2 & H1 FY23. Dr. Lal PathLabs Ltd - 539524 - Shareholder Meeting / Postal Ballot-Notice of Postal Ballot
Pursuant to Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, please find enclosed herewith Postal Ballot Notice dated November 08, 2022 ('Notice') together with the Explanatory Statement seeking approval of the Shareholders for the Resolution(s) as mentioned therein, through Postal Ballot by remote e-voting only ('remote e-voting'). Dr. Lal PathLabs Ltd - 539524 - Announcement under Regulation 30 (LODR)-Newspaper Publication
Pursuant to the Regulation 30 of the SEBI Listing Regulations, please find attached copies of newspaper advertisement of Financial Results of the Company for the quarter and half year ended on September 30, 2022, published in Financial Express and Jansatta on November 09, 2022.
Dr Lal PathLabs Q2 consolidated profit declines 25% to 72.4 cr
Its revenue from operations rose by 7.1 per cent to 533.8 crore during the period under review Dr. Lal PathLabs Ltd - 539524 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome
Pursuant to Regulation 30 and 46(2) of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, please note that the audio recording of the Company's Conference Call dated November 08, 2022 with Investors/ Analysts for Q2 & H1 - FY23 is available on the Company's website at https://www.lalpathlabs.com/investors/investors-inside/quarterly-result We request you to kindly take the same on record.